胡鑫渝,周浩,李丹,殷跃辉

• 1:重庆医科大学附属第二医院心血管内科

摘要(Abstract)：

目前去肾交感神经术面临着术后血压反应异质性较大的挑战，这项挑战既有手术患者选择性不足的因素，又受手术质量的影响。本文通过回顾文献，总结近年来开展去肾交感神经术的候选人群和手术疗效的潜在预测因子，并通过分析解剖位点经验性消融和肾神经功能检测方面的发展历程提出可改善手术精准度的方案，即运用肾动脉三维重建技术联合电刺激肾神经的血压反应来指导消融手术，这为去肾交感神经术的发展提供了新的思路。

关键词(KeyWords)： 去肾交感神经术;高血压;电刺激肾神经;三维重建;选择性消融

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金面上项目（32071110）

作者(Author): 胡鑫渝,周浩,李丹,殷跃辉

参考文献(References)：

• [1]Bhatt DL,Kandzari DE,O'Neill WW,et al.A controlled trial of renal denervation for resistant hypertension[J].N Engl J Med,2014,370(15):1393-1401.DOI:10.1056/NEJMoa1402670.
• [2]Townsend RR,Mahfoud F,Kandzari DE,et al.Catheterbased renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications(SPYRAL HTNOFF MED):a randomised,sham-controlled,proof-ofconcept trial[J].Lancet,2017,390(10108):2160-2170.DOI:10.1016/S0140-6736(17)32281-X.
• [3]Kandzari DE,Bohm M,Mahfoud F,et al.Effect of renal denervation on blood pressure in the presence of antihypertensive drugs:6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial[J].Lancet,2018,391(10137):2346-2355.DOI:10.1016/S0140-6736(18)30951-6.
• [4]Azizi M,Schmieder RE,Mahfoud F,et al.Endovascular ultrasound renal denervation to treat hypertension(RADIANCEHTN SOLO):a multicentre,international,single-blind,randomised,sham-controlled trial[J].Lancet,2018,391(10137):2335-2345.DOI:10.1016/S0140-6736(18)31082-1.
• [5]Bohm M,Kario K,Kandzari DE,et al.Efficacy of catheterbased renal denervation in the absence of anti hypertensive medications(SPYRAL HTN-OFF MED Pivotal):a multicentre,randomised,sham-controlled trial[J].Lancet,2020,395(10234):1444-1451.DOI:10.1016/S0140-6736(20)30554-7.
• [6]Mahfoud F,Kandzari DE,Kario K,et al.Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs(SPYRAL HTN-ON MED):a randomised,shamcontrolled trial[J].Lancet,2022,399(10333):1401-1410.DOI:10.1016/S0140-6736(22)00455-X.
• [7]Tanaka S,Okusa MD.Crosstalk between the nervous system and the kidney[J].Kidney Int,2020,97(3):466-476.DOI:10.1016/j.kint.2019.10.032.
• [8]刘健,王岚,孙浩宁.经导管去肾交感神经术治疗高血压:现状[J].中国介入心脏病学杂志,2022,30(7):499-502.DOI:10.3969/j.issn.1004-8812.2022.07.003.
• [9]van Amsterdam WA,Blankestijn PJ,Goldschmeding R,et al.The morphological substrate for renal denervation:Nerve distribution patterns and parasympathetic nerves.A post-mortem histological study[J].Ann Anat,2016,204:71-79.DOI:10.1016/j.aanat.2015.11.004.
• [10]Sakakura K,Ladich E,Cheng Q,et al.Anatomic assessment of sympathetic peri-arterial renal nerves in man[J].J Am Coll Cardiol,2014,64(7):635-643.DOI:10.1016/j.jacc.2014.03.059.
• [11]Tellez A,Rousselle S,Palmieri T,et al.Renal artery nerve distribution and density in the porcine model:biologic implications for the development of radiofrequency ablation therapies[J].Transl Res,2013,162(6):381-389.DOI:10.1016/j.trsl.2013.07.002.
• [12]Booth LC,Nishi EE,Yao ST,et al.Reinnervation of renal afferent and efferent nerves at 5.5 and 11 months after catheter-based radiofrequency renal denervation in sheep[J].Hypertension,2015,65(2):393-400.DOI:10.1161/HYPERTENSIONAHA.114.04176.
• [13]Singh RR,Mcardle ZM,Iudica M,et al.Sustained decrease in blood pressure and reduced anatomical and functional reinnervation of renal nerves in hypertensive sheep 30 months after catheter-based renal denervation[J].Hypertension,2019,73(3):718-727.DOI:10.1161/HYPERTENSIONAHA.118.12250.
• [14]Brouwers S,Sudano I,Kokubo Y,et al.Arterial hypertension[J].Lancet,2021,398(10296):249-261.DOI:10.1016/S0140-6736(21)00221-X.
• [15]Azizi M,Sanghvi K,Saxena M,et al.Ultrasound renal denervation for hypertension resistant to a triple medication pill(RADIANCE-HTN TRIO):a randomised,multicentre,single-blind,sham-controlled trial[J].Lancet,2021,397(10293):2476-2486.DOI:10.1016/S0140-6736(21)00788-1.
• [16]Ettehad D,Emdin CA,Kiran A,et al.Blood pressure lowering for prevention of cardiovascular disease and death:a systematic review and meta-analysis[J].Lancet,2016,387(10022):957-967.DOI:10.1016/S0140-6736(15)01225-8.
• [17]Tsioufis C,Dimitriadis K,Kasiakogias A,et al.Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome[J].J Hypertens,2017,35(5):1100-1108.DOI:10.1097/HJH.0000000000001262.
• [18]Steinberg JS,Shabanov V,Ponomarev D,et al.Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension:the ERADICATE-AF Randomized Clinical Trial[J].JAMA,2020,323(3):248-255.DOI:10.1001/jama.2019.21187.
• [19]Kresoja KP,Rommel KP,Fengler K,et al.Renal sympathetic denervation in patients with heart failure with preserved ejection fraction[J].Circ Heart Fail,2021,14(3):e7421.DOI:10.1161/CIRCHEARTFAILURE.120.007421.
• [20]Warchol-Celinska E,Prejbisz A,Kadziela J,et al.R enal denervation in resistant hypertension and obstructive sleep apnea:randomized proof-of-concept phase II trial[J].Hypertension,2018,72(2):381-390.DOI:10.1161/HYPERTENSION AHA.118.11180.
• [21]Hoogerwaard AF,Elvan A.Is renal denervation still a treatment option in cardiovascular disease?[J].Trends Cardiovasc Med,2020,30(4):189-195.DOI:10.1016/j.tcm.2019.05.006.
• [22]Ott C,Mahfoud F,Mancia G,et al.Renal denervation in patients with versus without chronic kidney disease:results from the Global SYMPLICITY Registry with follow-up data of 3 years[J].Nephrol Dial Transplant,2022,37(2):304-310.DOI:10.1093/ndt/gfab154.
• [23]Fengler K,Rommel KP,Lapusca R,et al.Renal denervation in isolated systolic hypertension using diferent catheter techniques and technologies[J].Hypertension,2019,74(2):341-348.DOI:10.1161/HYPERTENSIONAHA.119.13019.
• [24]Doumas M,Papademetriou V,Tsioufis C.Renal sympathetic denervation in isolated systolic hypertension[J].Hypertension,2019,74(2):255-256.DOI:10.1161/HYPERTENSIONAHA.119.13168.
• [25]Mahfoud F,Azizi M,Ewen S,et al.Proceedings from the3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies[J].Eur Heart J,2020,41(16):1588-1599.DOI:10.1093/eurheartj/ehaa121.
• [26]Kario K,Kagitani H,Hayashi S,et al.A Japan nationwide web-based survey of patient preference for renal denervation for hypertension treatment[J].Hypertens Res,2022,45(2):232-240.DOI:10.103 8/s41440-021-00760-9.
• [27]Schlaich MP,Carnagarin R,Ho JK,et al.Suitability for catheter-based renal denervation-lessons from'superresponders'[J].J Hypertens,2018,36(7):1475-1476.DOI:10.1097/HJH.0000000000001756.
• [28]Gosse P,Cremer A,Kirtane AJ,et al.Ambulatory blood pressure monitoring to predict response to renal denervation:a post hoc analysis of the RADIANCE-HTN SOLO study[J].Hypertension,2021,77(2):529-536.DOI:10.1161/HYPERTENSIONAHA.120.16292.
• [29]Lauder L,Azizi M,Kirtane AJ,et al.Device-based therapies for arterial hypertension[J].Nat Rev Cardiol,2020,17(10):614-628.DOI:10.1038/s41569-020-0364-1.
• [30]Bohm M,Tsioufis K,Kandzari DE,et al.Effect of heart rate on the outcome of renal denervation in patients with uncontrolled hypertension[J].J Am Coll Cardiol,2021,78(10):1028-1038.DOI:10.1016/j.j acc.2021.06.044.
• [31]Egan BM.Baseline heart rate predicts the blood pressure response to renal denervation in untreated hypertension[J].J Am Coll Cardiol,2021,78(10):1039-1041.DOI:10.1016/j.jacc.2021.07.019.
• [32]Burnier M.Ambulatory arterial stiffness index and blood pressureresponse to renal denervation[J].J Hypertens,2018,36(6):1272-1275.DOI:10.1097/HJH.0000000000001714.
• [33]Mahfoud F,Mancia G,Schmieder R,et al.Renal denervation in high-risk patients with hypertension[J].J Am Coll Cardiol,2020,75(23):2879-2888.DOI:10.1016/j.jacc.2020.04.036.
• [34]Fengler K,Rommel KP,Hoellriegel R,et al.Pulse wave velocity predicts response to renal denervation in isolated systolic hypertension[J].J Am Heart Assoc,2017,6(5):e005879.DOI:10.1161/JAHA.117.005879.
• [35]Sata Y,Hering D,Head GA,et al.Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation[J].J Hypertens,2018,36(6):1414-1422.DOI:10.1097/HJH.0000000000001682.
• [36]Mahfoud F,Townsend RR,Kandzari DE,et al.Changes in plasma renin activity after renal artery sympathetic denervation[J].JAm Coll Cardiol,2021,77(23):2909-2919.DOI:10.1016/j.jacc.2021.04.044.
• [37]Fengler K,Ewen S,Hollriegel R,et al.Blood pressure response to main renal artery and combined main renal artery plus branch renal denervation in patients with resistant hypertension[J].J Am Heart Assoc,2017,6(8):e006196.DOI:10.1161/JAHA.117.006196,
• [38]Chen W,Ling Z,Du H,et al.The effect of two different renal denervation strategies on blood pressure in resistant hypertension:comparison of full-length versus proximal renal artery ablation[J].Catheter Cardiovasc Interv,2016,88(5):786-795.DOI:10.1002/ccd.26594.
• [39]Imnadze G,Balzer S,Meyer B,et al.Anatomic patterns of renal arterial sympathetic innervation:new aspects for renal denervation[J].J Interv Cardiol,2016,29(6):594-600.DOI:10.1111/joic.12343.
• [40]Garcia-Touchard A,Maranillo E,Mompeo B,et al.Microdissection of the human renal nervous system:implications for performing renal denervation procedures[J].Hypertension,2020,76(4):1240-1246.DOI:10.1161/HYPERTENSIONAHA.120.15106.
• [41]TzafririAR,Mahfoud F,Keating JH,et al.Innervation patterns may limit response to endovascular renal denervation[J].J Am Coll Cardiol,2014,64(11):1079-1087.DOI:10.1016/j.jacc.2014.07.937.
• [42]Fengler K,Rommel KP,Blazek S,et al.A three-arm ra ndomized trial of different renal denervation devices and techniques in patients with resistant hypertension(RADIOSOUND-HTN)[J].Circulation,2019,139(5):590-600.DOI:10.1161/CIRCULATIONAHA.118.037654.
• [43]Pekarskiy SE,Baev AE,Mordovin VF,et al.Denervation of the distal renal arterial branches vs.conventional main renal artery treatment:a randomized controlled trial for treatment of resistant hypertension[J].J Hypertens,2017,35(2):369-375.DOI:10.1097/HJH.0000000000001160.
• [44]Gulas E,Wysiadecki G,Szymanski J,et al.Morphological and clinical aspects of the occurrence of accessory(multiple)renal arteries[J].Arch Med Sci,2018,14(2):442-453.
• [45]Schmieder RE,Mahfoud F,Mancia G,et al.European Society of Hypertension position paper on renal denervation2021[J].J Hypertens,2021,39(9):1733-1741.DOI:10.1097/HJH.0000000000002933.
• [46]Persu A,Maes F,Renkin J,et al.Renal denervation in hypertensivepatients:back to anatomy?[J].Hypertension,2020,76(4):1084-1086.DOI:10.1161/HYPERTENSIONAHA.120.15834.
• [47]Kiuchi MG,Esler MD,Fink GD,et al.Renal denervation update from the international sympathetic nervous system summit:JACC state-of-the-art review[J].J Am Coll Cardiol,2019,73(23):3006-3017.DOI:10.1016/j.jacc.2019.04.015.
• [48]Gal P,de Jong MR,Smit JJ,et al.Blood pressure response to renal nerve stimulation in patients undergoing renal denervation:a feasibility study[J].J Hum Hypertens,2015,29(5):292-295.DOI:10.1038/jhh.2014.91.
• [49]de Jong MR,Adiyaman A,Gal P,et al.Renal nerve stimulation-induced blood pressure changes predict ambulatory blood pressure response after renal denervation[J].Hypertension,2016,68(3):707-714.DOI:10.1161/HYPERTENSIONAHA.116.07492.
• [50]Liu H,Chen W,Lai Y,et al.Selective renal denervation guided by renal nerve stimulation in Canine[J].Hypertension,2019,74(3):536-545.DOI:10.1161/HYPERTENSIONAHA.119.12680.
• [51]Zhou H,Li Y,Xu Y,et al.Mapping renal innervations by renal nerve stimulation and characterizations of blood pressure response patterns[J].J Cardiovasc Transl Res,2022,15(1):29-37.DOI:10.1007/sl2265-021-10149-1.
• [52]Qian PC,Barry MA,Lu J,et al.Transvascular pacing of aorticorenal ganglia provides a testable procedural endpoint for renal artery denervation[J].JACC Cardiovasc Interv,2019,12(12):1109-1120.DOI:10.1016/j.jcin.2019.04.047.
• [53]Steinmetz M,Nelles D.Weisser-Thomas J,et al.Flow-mediated dilation,nitroglycerin-mediated dilation and their ratio predict successful renal denervation in mild resistant hypertension[J].Clin Res Cardiol,2018,107(7):611-615.DOI:10.1007/s00392-018-1236-0.
• [54]Lauder L,Moon LB,Pipenhagen CA,et al.A drug-induced hypotensive challenge to verify catheter-based radiofrequency renal denervation in an obese hypertensive swine model[J].Clin Res Cardiol,2022,111(6):595-603.DOI:10.1007/s00392-020-01764-0.
• [55]Gras si G,Mark A,Esler M.The sympathetic nervous system alterations in human hypertension[J].Circ Res,2015,116(6):976-990.DOI:10.1161/CIRCRESAHA.116.303604.
• [56]Weber MA,Mahfoud F,Schmieder RE,et al.Renal denervation for treating hypertension:current scientific and clinical evidence[J].JACC Cardiovasc Interv,2019,12(12):1095-1105.DOI:10.1016/j.jcin.2019.02.050.
• [57]Zaman S,Pouliopoulos J,Al RS,et al.Novel use of NavX three-dimensional mapping to guide renal artery denervation[J].Euro Intervention,2013,9(6):687-693.DOI:10.4244/EIJV9I6A112.
• [58]Kaczmarek K,Ptaszynski P,Krekora J,et al.A n electrophysiological approach using 3D electroanatomical mapping system for catheter-based renal denervation:the first Polish experience[J].Kardiol Pol,2013,71(9):990.DOI:10.5603/KP.2013.0241.
• [59]孙宁玲.2021年欧洲高血压学会关于经导管去肾交感神经术的立场文件详介[J].中国介入心脏病学杂志,2021,29(10):548-553.DOI:10.3969/j.issn.1004-8812.2021.10.002.